Cardinal Health Sells its Cordis Cardiology Business to Hellman & Friedman
Cardinal Health Sells its Cordis Cardiology Business to Hellman & Friedman Investment company hopes to create technology accelerator to speed bringing new innovations to market March 12, 2021 — Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to Hellman & Friedman (H&F) for approximately $1 billion. Hellman & Friedman is a global private equity firm with investments in high-quality growth businesses. It is partnering in the transaction with Ajax Health and Zeus Health to build the Cordis business. Ajax identifies and supports scaling up di...
Source: dicardiology.com